| 2026-10-26 | Economic Evaluation of an E-Dengue Early Warning System for Proactive Dengue Prevention in the Mekong Delta Region, Vietnam: A Protocol | PharmacoEconomics - Open | Trinh Manh Hung, Kim-Huong Nguyen, Hugo C. Turner et al. | The University of Queensland; Trinity College Dublin; Imperial College London; … |
| 2026-10-26 | Home-Based Versus Hospital-Based Administration of Enzyme Replacement Therapy for Late-Onset Pompe Disease in Greece: A Cost-Utility and Budget Impact Analysis | Applied Health Economics and Health Policy | Persefoni Kritikou, Gregory F. Guzauskas, Constantinos Papadopoulos et al. | National and Kapodistrian University of Athens; Eginition Hospital |
| 2026-10-26 | Cost-effectiveness of antiviral therapies for hospitalized COVID-19 patients at Dr. Hasan Sadikin Hospital, Indonesia: a retrospective real-world analysis | Cost Effectiveness and Resource Allocation | Cherry Rahayu, Rano Kurnia Sinuraya, Vesara Ardhe Gatera et al. | Padjadjaran University |
| 2026-10-26 | Families caring for children and adolescents with rare disease: a health economic evaluation of face-to-face and online psychosocial support intervention of the randomized controlled CARE-FAM-NET study | Health Economics Review | Nicolas Pardey, Kristine Kreis, Anna Leidger et al. | Leibniz University Hannover; University Medical Center Hamburg-Eppendorf; University Hospital Ulm; … |
| 2026-10-25 | Measuring the Health of Young Children | PharmacoEconomics | Daniel M. Hausman | University of Wisconsin–Madison |
| 2026-10-24 | Modelling the potential contributions of polygenic risk stratification to cost-effective screening for prostate cancer | The European Journal of Health Economics | Padraig Dixon, Jonathan J. Aning, Richard Michael Martin et al. | University of Oxford; North Bristol NHS Trust; University of Bristol; … |
| 2026-10-23 | A cost-effectiveness analysis of trastuzumab deruxtecan for HER2-low metastatic breast cancer: applying a Saudi economic evaluation guideline | Health Economics Review | Fatma Maraiki, Tusneem Ahmed M. Elhassan, Shouki N. Bazarbashi et al. | Griffith University; Alfaisal University; King Faisal Specialist Hospital & Research Centre; … |
| 2026-10-22 | Towards meaningful outcome measures for health economic evaluations in skin cancer | Cost Effectiveness and Resource Allocation | Annick Meertens, Lieven Annemans, Floor Verstraete et al. | Ghent University Hospital; Ghent University; Cancer Research Institute Ghent |
| 2026-10-20 | Cost-effectiveness of iStent-based trabecular micro-bypass stenting combined with cataract surgery in mild-to-moderate open-angle glaucoma: a systematic review of analytic perspectives and time horizons | Cost Effectiveness and Resource Allocation | Dan Drobin | Karolinska Institutet |
| 2026-10-20 | Economic evaluation of the Be-Prox anti-bullying intervention in Norwegian early childhood education and care settings: an exploratory partial within-trial cost-effectiveness analysis alongside a cluster randomised controlled trial | Cost Effectiveness and Resource Allocation | Renira C. Angeles, Ingrid Kvestad, Merete Aasheim et al. | NORCE Research AS; UiT The Arctic University of Norway |
| 2026-10-20 | Short-term cost-effectiveness of siltartoxatug versus human tetanus immunoglobulin for post-traumatic tetanus prophylaxis in Chinese adults: a trial-based economic evaluation | Cost Effectiveness and Resource Allocation | Jianrun Zhang, Yuan Xiao, Liwu Huang et al. | First Affiliated Hospital of Guangzhou Medical University; Guangzhou First People's Hospital; South China University of Technology; … |
| 2026-10-16 | Cost Effectiveness of Sertraline for Preventing Domestic Violence Reoffending Among Highly Impulsive Violent Offenders in Australia: A Trial-Based Economic Evaluation | Applied Health Economics and Health Policy | Emaediong Ibong Akpanekpo, Georgina Mary Chambers, Lee Knight et al. | UNSW Sydney; Centre for Big Data Research in Health; Hunter New England Local Health District; … |
| 2026-10-15 | Cost-Effectiveness of Community Health Worker Interventions for Type 2 Diabetes Mellitus: A Systematic Review | Applied Health Economics and Health Policy | Laura R. Porterfield, H. Shelton Brown, Dallin C. Swanson et al. | The University of Texas Medical Branch at Galveston; Stanford Medicine; Baylor College of Medicine |
| 2026-10-15 | Home-based geriatric rehabilitation after shortened inpatient rehabilitation: cost-effectiveness analysis of the “Better@Home” multicentre prospective cohort study with a matched historical control group | The European Journal of Health Economics | Chris J. Gamble, Wim G Groen, M. Vaz et al. | Maastricht University; Care and Public Health Research Institute; Amsterdam Public Health; … |
| 2026-10-14 | Cost-effectiveness of virtual reality-based avatar therapy for patients with treatment-resistant schizophrenia | Health Economics Review | Alexandrina Stoyanova, Raquel Andres, Edit Vass et al. | Universitat de Barcelona; Semmelweis University; Parc Sanitari Sant Joan de Déu; … |
| 2026-10-09 | Methodological Challenges and Preferred Approaches for the Economic Evaluation of CAR T Therapies: Evidence Review and Expert Consensus from NICE Appraisals | PharmacoEconomics | Mehdi Yousefi, Amin Mehrabian, Maeve A O'Reilly et al. | University of Birmingham; University College Hospital; University of Exeter |
| 2026-10-09 | Cost-Effectiveness of Annual Atrial Fibrillation Screening Compared with Current Opportunistic Screening in Australian Primary Care: A Model-Based Economic Evaluation | Applied Health Economics and Health Policy | Ureni Halahakone, Sameera Jayan Senanayake, Victoria McCreanor et al. | Queensland University of Technology; National University of Singapore; Duke-NUS Medical School; … |
| 2026-10-09 | Influenza disease burden investigation and cost-effectiveness analysis based on system dynamics model | The European Journal of Health Economics | Lei Cao, Yu Shao, Zhen Zhang et al. | |
| 2026-10-07 | Cost-effectiveness of maternal Tdap immunisation in Sabah, Malaysia: a historical evaluation of the 2018 birth cohort | Cost Effectiveness and Resource Allocation | Abraham Chiu En Loong, Mohd Yusof Ibrahim, Abdul Rahman Ramdzan et al. | Universiti of Malaysia Sabah; Universitas Pembangunan Nasional Veteran Jakarta |
| 2026-10-06 | Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review | Cost Effectiveness and Resource Allocation | Zehui Jiang, Nannan Yan, Dongxiao Chen et al. | Jiangxi University of Traditional Chinese Medicine; People's Liberation Army 401 Hospital |
| 2026-10-05 | Cost-effectiveness of early empagliflozin initiation after acute myocardial infarction: a German statutory health insurance perspective | Cost Effectiveness and Resource Allocation | Priyanka Boettger, Eleni S. Nakou, Thomas Kinsley et al. | Justus-Liebig-Universität Gießen; Cardio-Pulmonary Institute; London School of Economics and Political Science; … |
| 2026-10-02 | Cost-Effectiveness Analysis of Ribociclib plus an Aromatase Inhibitor (AI) Versus AI Alone in the Adjuvant Treatment of Stage II and III Pre- and Postmenopausal Women with HR+/HER2− Early Breast Cancer (EBC): A Canadian Payer Perspective | PharmacoEconomics - Open | Dina Soliman, Christine Brezden‐Masley, Sandeep R. Sehdev et al. | Novartis (Canada); Mount Sinai Hospital; Ottawa Hospital |